BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16219662)

  • 1. Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism.
    Raikwar NS; Cho WK; Bowen RF; Deeg MA
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E463-70. PubMed ID: 16219662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy reduces serum levels of glycosylphosphatidylinositol-specific phospholipase D.
    Deeg MA; Raikwar NS; Johnson C; Williams CD
    Transl Res; 2007 Sep; 150(3):153-7. PubMed ID: 17761367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose and insulin regulate glycosylphosphatidylinositol-specific phospholipase D expression in islet beta cells.
    Bowen RF; Raikwar NS; Olson LK; Deeg MA
    Metabolism; 2001 Dec; 50(12):1489-92. PubMed ID: 11735099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic regulation of mouse glycosylphosphatidylinositol-phospholipase D.
    Flores-Borja F; Kieszkievicz J; Church V; Francis-West PH; Schofield J; Rademacher TW; Lund T
    Biochimie; 2004; 86(4-5):275-82. PubMed ID: 15194230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletions of helices 2 and 3 of human apoA-I are associated with severe dyslipidemia following adenovirus-mediated gene transfer in apoA-I-deficient mice.
    Chroni A; Kan HY; Shkodrani A; Liu T; Zannis VI
    Biochemistry; 2005 Mar; 44(10):4108-17. PubMed ID: 15751988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles.
    Qi K; Fan C; Jiang J; Zhu H; Jiao H; Meng Q; Deckelbaum RJ
    Clin Nutr; 2008 Jun; 27(3):424-30. PubMed ID: 18362042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 12-week, prospective, open-label analysis of the effect of rosuvastatin on triglyceride-rich lipoprotein metabolism in patients with primary dyslipidemia.
    Kostapanos MS; Milionis HJ; Filippatos TD; Nakou ES; Bairaktari ET; Tselepis AD; Elisaf MS
    Clin Ther; 2007 Jul; 29(7):1403-14. PubMed ID: 17825691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glycosylphosphatidylinositol specific phospholipase D gene expression levels on complement mediated killing of leukemic cells in patients with chronic myeloid leukemia.
    Jian-Hua T; Xiao-Jie Z; Yi-Dan W; Wen-Kai L; Wang-Jiao H; Cheng-Hong W; Gui-Yuan L
    Clin Chim Acta; 2005 Sep; 359(1-2):115-24. PubMed ID: 15907827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of apolipoprotein E isoforms on lipolysis of very low-density lipoprotein triglycerides.
    Hara M; Iso-O N; Satoh H; Noto H; Togo M; Ishibashi S; Kimura S; Kadowaki T; Hashimoto Y; Tsukamoto K
    Metabolism; 2006 Aug; 55(8):1129-34. PubMed ID: 16839851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
    Coenen KR; Hasty AH
    Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E492-9. PubMed ID: 17566116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylphosphatidylinositol-specific phospholipase D immunoreactivity is present in islet amyloid in type 2 diabetes.
    Larson DM; Kennedy MA; Bowen RF; Verchere CB; Deeg MA
    J Pathol; 2004 Aug; 203(4):961-7. PubMed ID: 15259000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPI-specific phospholipase D (GPI-PLD) is expressed during mouse development and is localized to the extracellular matrix of the developing mouse skeleton.
    Gregory P; Kraemer E; Zürcher G; Gentinetta R; Rohrbach V; Brodbeck U; Andres AC; Ziemiecki A; Bütikofer P
    Bone; 2005 Aug; 37(2):139-47. PubMed ID: 15946906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesteryl ester transfer protein (CETP) increases postprandial triglyceridaemia and delays triacylglycerol plasma clearance in transgenic mice.
    Salerno AG; Patrício PR; Berti JA; Oliveira HC
    Biochem J; 2009 May; 419(3):629-34. PubMed ID: 19191759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerotic lesion formation and triglyceride storage in obese apolipoprotein AI-deficient mice.
    Plummer MR; Hasty AH
    J Nutr Biochem; 2008 Oct; 19(10):664-73. PubMed ID: 18280133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible involvement of enhanced intestinal microsomal triglyceride transfer protein (MTP) gene expression in acceleration of lipid absorption by a western-type diet in apolipoprotein E knockout mice.
    Ueshima K; Akihisa-Umeno H; Sawada M; Nagayoshi A; Ozaki T; Takakura S; Manda T; Mutoh S
    Life Sci; 2004 Nov; 76(2):179-90. PubMed ID: 15519363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of phosphatidylethanolamine N-methyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice.
    Zhao Y; Su B; Jacobs RL; Kennedy B; Francis GA; Waddington E; Brosnan JT; Vance JE; Vance DE
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1349-55. PubMed ID: 19520976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midportion antibodies stimulate glycosylphosphatidylinositol-specific phospholipase D activity.
    Deeg MA; Bowen RF
    Arch Biochem Biophys; 1999 Oct; 370(2):278-84. PubMed ID: 10510287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-mouse GPI-PLD antisera highlight structural differences between murine and bovine GPI-PLDs.
    Gregory P; Ziemiecki A; Zürcher G; Brodbeck U; Bütikofer P
    Biol Chem; 2003 Dec; 384(12):1575-82. PubMed ID: 14719799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPI-specific phospholipase D as an apolipoprotein.
    Deeg MA
    Braz J Med Biol Res; 1994 Feb; 27(2):375-81. PubMed ID: 8081252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study.
    Chalasani N; Vuppalanchi R; Raikwar NS; Deeg MA
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2279-85. PubMed ID: 16595594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.